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============

**What was known?**

Toenail mycoses involve mainly dermatophytes but when *Candida* is also involved, the strain most commonly isolated worldwide is *C albicans*.

Approximately 20% of individuals aged between 40 and 60 have onychomycosis.\[[@ref1][@ref2]\] Three main groups of fungi are involved: dermatophytes, yeasts of the *Candida* genus and molds.

The role of *Candida* species in the production of onychomycosis has been largely discussed. Over years, nail candidiasis was considered only as those cases related to hand paronychia. Progress in mycology has finally recognized candida\'s ability to invade the nail plate and cause nail disorders indistinguishable from those generated by dermatophytes.

*Candida albicans* and *Candida parapsilosis*, among others, may be commensals and be part of the skin normal flora; however in immunodeficiency settings they are able to cause severe systemic infections. Systemic infections caused by *Candida albicans* are widely known, but *Candida parapsilosis* is emerging as culprit for severe infections among inpatients.\[[@ref3]\] In a 10-year-study conducted in Texas, *C. glabrata* was associated to candidemia in patients with hematological malignancies, favored by neutropenia. *C. parapsilosis* was associated to the use of central venous catheters, a finding in accordance with the reports of Warnock.\[[@ref4][@ref5]\] *C. tropicalis* is emerging as an important pathogen in neutropenic patients and *C. parapsilosis* is doing so among patients receiving transparentheral nutrition. *C. glabrata* and *C. krusei* have rapidly developed resistance to fluconazole.\[[@ref5]\]

In general it is accepted that patients undergoing nail candidiasis must have an intercurrent disease able to cause immunosuppression. Among the latter are HIV/AIDS, diabetes, circulation disorders, connective tissue diseases and prolonged immunosuppressive therapy with cytostatics or steroids. However, various recent studies have demonstrated the role of *Candida* in the generation of onychomycosis without referring to underlying causes, where *Candida* has been responsible for a very variable percentage of onychomycosis, between 3,5 and 58,5%.\[[@ref1][@ref6][@ref7][@ref8][@ref9]\]

When nail candidiasis associates to fingernail paronychia, particularly in women who keep their hands under soapy water for long periods of time, clinical diagnosis is simple and mycological exam just confirms a clinical suspicion. The case of toenail onychomycoses, either distal-lateral subungual or total dystrophic forms, is different. In such cases, the finding of *Candida* in a mycologic test must meet certain requirements for *Candida* to be considered the causal agent.

Recently, *Candida* is coming into sight as an important cause of onychomycosis, as confirmed by studies from India and Spain, where their authors are proving that *Candida* is the main cause of onychomycosis in their geographical location.\[[@ref2][@ref10]\] In an American study involving eleven states between 1997 and 2002, *Candida* was responsible for 70% of onychomycoses, especially in cases affecting fingernails.\[[@ref8]\]

Internationally, there is not one common criterion to attribute the etiology of onychomycoses to *Candida*. The analysis of various works shows that methods differ in the number of inocula required to be positive. There are also differences in whether the repetition of the test twice or more is required to attribute the cause of the nail affection to a non-dermatophyte fungus.

Walshe and English criteria for the diagnosis of molds in onychomycoses, proposed in 1966, refer to the number of nail fragments positive for the suspected fungus. Five or more than twenty inocula in the absence of dermatophytes and a compatible direct test would be enough to make an etiologic diagnosis.\[[@ref11]\] However, in 2001 Gupta *et al*. demonstrated that such method issued the correct diagnosis only in 23.2% of the cases.\[[@ref7]\]

The prevalence of *Candida* onychomycoses and the species more commonly involved are a key issue to assess. As previously stated, the review of current works shows that the epidemiology of *Candida* onychomycosis is different depending on the geographical location. Undoubtedly, the most commonly reported species is albicans, both among adults and children.\[[@ref1][@ref12][@ref13][@ref14][@ref15]\] however, the emergence of other species in various sites of the world is pointing towards a change in epidemiological behavior of the disease: *C. krusei*, *C. glabrata*, *C. parapsilosis* and *C. tropicalis* in India and Singapore.\[[@ref2][@ref16]\] *C. tropicalis* and *C. guillermondii* in Malta.\[[@ref17]\] *C. parapsilosis*, *C. tropicalis* and *C. guillermondii* in Brazil.\[[@ref18]\] *C. parapsilosis*, *C. albicans* and *C. glabrata* in Mexico,\[[@ref19]\] *C. guillermondii* and *C. albicans* in Germany,\[[@ref20]\] and *C. tropicalis*, *C. albicans*, *C. glabrata* and *C. krusei* in Turkey.\[[@ref21]\] In Sao Paulo nail candidiasis outnumbered nail dermatophytosis, with *C. albicans* and *C. parapsilosis* being found more commonly, in the same order, particularly in fingernail onychomycosis.\[[@ref22]\] Among the isolated species of *Candida* there are some resistant to various commonly used antifungals, such as *Candida glabrata* which is resistant to imidazoles.\[[@ref16]\]

Our objective was to evaluate the presence of various *Candida* species in *Candida* onychomycosis, and to assess their relative significance, in order to either confirm the need to modify our management protocols or to continue with therapies currently used.

Materials and Methods {#sec1-2}
=====================

A retrospective, observational and descriptive study of 8443 fungal cultures was performed. Mycological cultures taken within the health network of Pontificia Universidad Católica and concentrated at the Laboratory of the Centro Médico San Joaquín were reviewed. The three year analysis period included specimens from December 2007 to December 2010. Specimens of nails were collected scrapping the surface of the nail plates to perform a direct microscopy study after treatment with 20% potassium hydroxide and were seeded on Sabouraud glucose agar with the addition of chloramphenicol and lactrimel agar, for 25 days incubation at 30°C, with periodic revision and observation. Yeast identification was achieved with the germinative tube test and through commercial tests of the API ID 32C system, BioMerieux (France), as per manufacturer\'s specifications.

The strains ATCC 90028 (*Candida albicans*), ATCC 9968 (*Candida tropicalis*) and ATCC 64677 (*Candida glabrata*) were used as controls.\[[@ref23][@ref24]\]

Wherever available, files of patients who had a positive culture for *Candida* were analyzed for clinical information like their age, gender, underlying illnesses and/or use of immunosuppressive agents during the trial.

A descriptive statistical analysis was performed, because we have included all the specimens obtained from patients attending the healthcare network between December 2007 and December 2010. We have not excluded any of them from the study.

Results {#sec1-3}
=======

A total of 8443 nail specimens were analyzed. Of the total of specimens analyzed, 3123 were positive (36.9%). *Candida* grew in 467 specimens (15%), of which 223 were from toenails (47.8%) and 244 from fingernails (52.2%) \[[Table 1](#T1){ref-type="table"}\]. The isolated *Candida* species were mainly *C. parapsilosis*, in 202 cases (43.3%), *C. guillermondii* in 113 (24,2%) and *C. albicans* in 110 cases (23,6%). Together the 3 strains represented 91.1% of all *Candida* detections.
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Dermatophytes were isolated from 2637 specimens and they accounted mainly for *T. rubrum* (88,2%) and *T. mentagrophytes* (11.6%) \[[Table 2](#T2){ref-type="table"}\]. Molds were isolated from 18 specimens, with Fusarium sp being the most common, accounting for 61% of mold isolates \[[Table 3](#T3){ref-type="table"}\]. When analyzing the proportion of *Candida* species per year, an increase of *C. parapsilosis* in 25.62% is evidenced \[[Table 1](#T1){ref-type="table"}\].
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Among the 467 patients with positive cultures for *Candida*, 136 (29,1%) were men and 331 (70,9%) were women. All patients were older than 18 yrs old. Clinical files were available for only 169 of the 467 patients with positive cultures for *Candida*. For those patients, age, gender, underlying illnesses and use of immunossupresive agents during the trial were reviewed. Among those patients, 14 (8%) had type 2 diabetes, 11 (7%) connective tissue disorders, 9 (5%) psoriasis, 3 (2%) inflammatory bowel disease, 1 (1%) HIV, 1 (1%) hepatic cirrhosis and 1 (1%) Ewing Sarcoma. 13 (8%) of the patients who were suffering underlying illnesses where receiving immunosuppressive therapy with prednisone, methotrexate or azathioprine, for more than a year.

Discussion {#sec1-4}
==========

The analysis of results revealed that, *Candida* represents 15% of all studied onychomycoses, and that it affected fingernails and toenails with similar rates.

The results of Chilean studies reported in 1981 showed that *Candida* accounted for 25.6% of all onychomycoses, those reported in 1987 evidenced that *Candida* accounted for 51% of all onychomycoses.\[[@ref25][@ref26]\] It is worth noting that in occasions, Candida presents as the only agent and in others it is a concomitant agent together with molds or dermatophytes. The coexistence of a dermatophyte with yeasts or molds in the mycological test, is very indicative of a dermatophyte as the real culprit for the problem.\[[@ref27]\]

Gender is also a factor that has an impact on results, since *Candida* is more common in women who permanently get their hands wet. Such circumstances might explain the differences seen in different studies, where proportions of specimens from women and men differ.

In our work, the most striking fact is the predominance of *C. parapsilosis*, accounting for 43.3% of the cases studied, and that is twice as frequent as *C. guillermondii* and *C. albicans*. That the proportion of *C. parapsilosis* in nails increases in a sustained manner between 2008 and 2010, while *C. albicans* and *C. guillermondii* do not follow such a growth curve and stay in relatively stable proportions, is striking \[[Figure 1](#F1){ref-type="fig"}\].
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We could also infer that most of the patients with nail candidiasis do not present comorbidities which could alter their host immunity, as has been described in the literature and that coincides with foreign publications. However, a clinical evaluation is recommended in patients with candida infection.

It is very common to see that in published reports mycology analyses of the skin and adnexae just refer to *C. albicans* and *C. spp*. Because mycosis epidemiology is a constantly evolving phenomenon, nail candidiasis caused by species other than *albicans* might be expected to have a role as a gateway to systemic candidiasis, thus implying an additional concern for clinical and therapeutic aspects.

An oncology institute in Slovakia reported *C. krusei*, *C. parapsilosis*, *C. glabrata*, *C. tropicalis* and *C. guillermondii* fungaemia over 10 years, there were 45 *non-albicans C.* fungaemias as compared to 75 *C. albicans* fungaemias.\[[@ref28]\]

*Candida* fungaemia behavior has been changing in time. In Slovakia, until 1990, *non-albicans Candida* accounted for 10-40% of all candidemias, while between 1991-1998 it accounted for 35-65%. The most common species were *C. parapsilosis*, *C. tropicalis* and *C. glabrata*. Remarkably, *C. krusei* and *C. glabrata* were resistant to fluconazole and *C. lusitaniae* and *C. rugosa* were resistant to amphotericin B.\[[@ref29]\]

*Non-albicans Candida* incidence has proved to be higher than that of *C. albicans* (54.4% vs. 45.6%). While *C. krusei* relates to the prior use of antifungals, hematological malignancies, neutropenia, stem-cell transplant and steroid therapy,\[[@ref30]\] *C. parapsilosis* has been associated to endocarditis in intravenous drug abusers and nosocomial infections such as septic arthritis, peritonitis and endophthalmitis and invasive medical instrumentation. Between 1989 and 1992, *C. krusei* was responsible for 5% of fungaemias in Houston, and between 1993-1996 such figure increased to 10%. It presented especially among patients with leukemia and *C. albicans* related to catheter use. In neutropenic patients, *C. krusei* was associated to higher mortality rates (49%) than *C. albicans* (28%).\[[@ref31]\]

The frequency of *C. parapsilosis* in nosocomial infections related to skin colonization, particularly the subungual space and oral cavity, has increased. In Taiwan, from a group of 323 healthy volunteers, 15.2% had oral cavity colonization by *Candida*, with *C. albicans* accounting for 57.7% and *C. parapsilosis* accounting for 15.4% of cases.\[[@ref32]\]

The sensitivity of various *Candida* species varies in different countries. A decrease in the susceptibility of *C. parapsilosis* to amphotericin B, 5-fluorocytosine but a good susceptibility to imidazole drugs have been reported.\[[@ref33][@ref34]\]

A study conducted in Venezuela with inpatients, revealed different *Candida* species have different susceptibility to the different antimycotic drugs. *C. albicans* showed sensitivity to fluconazole in 92.6%, *C. tropicalis* in 87.1% and *C. glabrata* in 56.7%. Also, all the studied strains were sensitive to amphotericin B and voriconazole.\[[@ref35]\] Another study reveals that *C. krusei* and *C. glabrata* are poorly sensitive to fluconazole and the resistance increase is suggested to be a consequence of the frequent prophylactic use of fluconazole.\[[@ref36]\] The association between *non-albicans* species has been observed in Japan in fluconazole-related candidemias. While *C. tropicalis*, *C. parapsilosis* and *C. guillermondii* were sensitive to therapy, *C. glabrata* and *C. krusei* were less sensitive. Moreover, *C. parapsilosis* and *C. guillermondii* had a high minimal inhibitory concentration (MIC) for micafungin.\[[@ref37]\]

In Kuwait, the species most commonly isolated from blood cultures was *C. albicans* (39,5%) as opposed to *C. parapsilosis* that was isolated from 30,6% of the cases. Interestingly, all the strains were sensitive to voriconazole and resistance to amphotericin B and fluconazole was persistently low, in spite of the routine use of such drugs in systemic candidiasis.\[[@ref38]\] Authors suggest the use of voriconazole to treat infections caused by fluconazole and itraconazole -- resistant yeast.\[[@ref39]\]

With regard to cell wall inhibitors such as echinocandins, *C. albicans* has also been revealed as the most sensitive species, while *C. glabrata*, *C. tropicalis* and *C. krusei* are less sensitive; *C. parapsilosis* and *C. guillermondii* are intrinsically resistant by virtue of specific mutations.\[[@ref40]\]

A study published in Spain revealed the best MIC of amphotericin B for *C. albicans*, higher than the MIC obtained for *C. tropicalis*, *C. glabrata* and *C. parapsilosis*.\[[@ref41]\]

*In vitro* sensitivity of various *Candida* species to various polyene formulations (amphotericin, nystatin) and itraconazole revealed seldom differences between themselves. However, sensitivity to polyenes is superior than sensivity to fluconazole.\[[@ref42]\]

There is evidence that terbinafine has good therapeutic results in *C. parapsilosis*, but not in other species of *Candida*; this could lead to the conclusion that terbinafine may be useful in the treatment of nail candidiasis adding a new therapeutic tool.\[[@ref43][@ref44]\]

To date there are no evidences of a literature reference showing the results presented herein concerning the proportional increase of *C. parapsilosis* in nail candidiasis. It is worth noting that the works published do not express rates but simple percentages since studies do not involve a defined assigned population. Laboratories receive specimens from all centers without considering specific populations. Moreover, they refer to the consulting population, thus inducing a bias.

In the future, we should assess the prevalence of onychomycosis in the general population to really appreciate the magnitude of this public health issue.

**What is new?**

The present study shows that both **C. parapsilosis** as well as **C. guillermondii** appear as emerging pathogens that would be in fact taking the place of **C. albicans** as the most commonly isolated pathogen in patients with *Candida onychomycosis*.Identification of *Candida* strains as etiological agents of nail candidiasis becomes relevant to the management both nail as well as systemic candidiasis, in view of the resistance to conventional treatments readily reported in the literature.
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